A Prospective Observational Study on Drug Utilisation Pattern of Restricted Antibiotics: Colistin, Teicoplanin and Tigecycline in a Tertiary Care Hospital

Introduction: The emergence of antimicrobial resistance is a global threat. Now microorganisms manage to overcome the antibiotics via various resistance mechanisms. This study was carried out to evaluate the appropriate usage and resistance pattern of the restricted antibiotics. Methods: A prospective observational study on Drug Utilization Pattern of Colistin, Teicoplanin and Tigecycline were conducted during the period of February 2016 – July 2016 at G. Kuppusamy Naidu Memorial Hospital, coimbatore, Tamil Nadu. Results: Out of 103 patients, 55 patients were treated empirically and 48 were treated based on their culture report. The antibiotics were prescribed mostly for patients with positive culture report followed by neutropenia patients and De-escalation was done only in 14 cases. The antibiotics were mostly consumed by patients in oncology department. On calculating the defined daily dose (DDD) Colistin was used predominantly, followed by teicoplanin and tigecycline. Conclusion: A stewardship Program must be implemented in the hospital to improve overall antibiotic usage in hospital. By this, we could reduce the emergence of antibiotic resistance up to a certain extent, by implementing a restricted antibiotic order form and proper follow up could add up to reduced antibiotic consumption.

[1]  J. Garnacho-Montero,et al.  Antibiotic de-escalation in the ICU: how is it best done? , 2015, Current opinion in infectious diseases.

[2]  R. Foà,et al.  Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  E. Horwitz,et al.  Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patients , 2013, Infection.

[4]  J. Salamzadeh,et al.  A Drug Utilization Evaluation Study of Amphotericin B in Neutropenic Patients in a Teaching Hospital in Iran , 2012, Iranian journal of pharmaceutical research : IJPR.

[5]  A. Mathai,et al.  Antibiotic prescription patterns at admission into a tertiary level intensive care unit in Northern India , 2011, Journal of pharmacy & bioallied sciences.

[6]  Joshua D. Hartzell,et al.  Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  G. Maartens,et al.  Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections , 2009, BMC infectious diseases.

[8]  H. Cheong,et al.  In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. , 2007, The Journal of antimicrobial chemotherapy.

[9]  M. Falagas,et al.  Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  C. Brun-Buisson,et al.  Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation. , 2000, The Journal of antimicrobial chemotherapy.

[11]  K. Prabhakar,et al.  Blood Culture - A must and of Utmost Importance In Medical Intensive Care Wards , 2014 .

[12]  B. K. Gelaw,et al.  Drug utilization review of ciprofloxacin in the outpatient department of Boru Meda Hospital, South Wollo Zone, Amhara Region, Ethiopia - , 2014 .

[13]  M. Mohammadi,et al.  Drug Use Evaluation of Three Widely Prescribed Antibiotics in a , 2013 .

[14]  A. Karabinis,et al.  Colistin for Klebsiella pneumoniae-associated sepsis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  M. Sd,et al.  Drug utilization: a regional approach. , 1995 .